Neomycin + Polymyxin B + Dexamethasone Ophthalmic Drops
62 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
62
Total Reports
1
Deaths Reported
160.0%
Death Rate
Active Ingredients
Neomycin + Polymyxin B + Dexamethasone Ophthalmic Drops
Administration Routes
OphthalmicIntraocularUnknownOral
Species Affected
Dog 60
Cat 2
Most Affected Breeds
Retriever - Labrador 10
Bulldog 6
Spaniel - Cocker American 5
Bichon Frise 3
Shih Tzu 3
Pekingese 3
Pug 2
Shepherd Dog - German 2
Boxer (German Boxer) 2
Domestic Shorthair 2
Most Reported Reactions
Vomiting 18
Emesis 16
Lethargy (see also Central nervous system depression in 'Neurological') 11
Decreased appetite 4
Diarrhoea 4
Lack of efficacy - NOS 4
Behavioural disorder NOS 3
Other ear disorder NOS 3
Vocalisation 3
Scleritis 2
Seizure NOS 2
Ear infection NOS 2
Outcome Breakdown
Recovered/Normal
39 (62.9%)
Outcome Unknown
12 (19.4%)
Ongoing
8 (12.9%)
Recovered with Sequela
2 (3.2%)
Euthanized
1 (1.6%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.